AURKB and nonpapillary renal cell carcinoma: MTT assay showed that E2F1 knockdown inhibited ccRCC cell proliferation, while AURKB overexpression partially reversed the inhibitory effect of E2F1 knockdown on ccRCC cell proliferation (Fig. 8F).